Tesla’s (NASDAQ:TSLA) CEO Elon Musk Taking ‘Refuge’ in Tequila
Tesla’s (NASDAQ:TSLA) Musk Controlled Board Needs More Manufacturing Expertise
Elon Musk, 47 anni, is smart, maybe brilliant and larger than life for many of his cultish followers. And like outstanding entrepreneurs before him, there comes a time when breaking all the rules has adverse effects.
For him the time is now, as he is out as Chairman of his rubber stamp Board.
Speculation is that James Murdoch will become the Chairman of Tesla. Mr. Murdoch, son of media mogul Rupert Murdoch has been on the board of Tesla since last year.
The Bog Q: Can Mr. Murdoch have the independence and authority to regulate Mr. Musk?
As Tesla’s Chairman, Mr. Murdoch would oversee the Tesla board of other family and friends of Mr. Musk. A total of 9 directors including Messrs Musk and Murdoch does not have anyone with automotive industry experience, none.
These deficiencies at the board level have allowed Mr. Musk total rein over the company, which has contributed to the current dire straits Tesla find itself in today, including its lack of profitability to the verge of bankruptcy.
Tesla’s board has media, entertainment, and investing experience par excellence and none is better that James Murdoch, he has the reach.
As innovative as Mr. Musk is, now he must accept that he has serious limitations. Knowing how to create a team with relevant and complimentary skills and experience may be the toughest challenge any innovator faces, so the inevitable may be happening right in front of us now.
Tesla’s CEO Musk Tweeted Friday: “Teslaquila coming soon …” And he was quick to offer his Twitter followers a mock-up of the “Teslaquila” logo.
Caution, Tesla is no longer an investment grade stock, it is a speculation for professionals only.
|HeffX-LTN Analysis for TSLA:||Overall||Short||Intermediate||Long|
|Bearish (-0.26)||Neutral (-0.23)||Neutral (-0.19)||Bearish (-0.38)|
Latest posts by Paul Ebeling (see all)
- The Key Reasons for Australia to Exit the Paris Accord Now - January 17, 2019
- Stem Cell Therapy May Be Treatment for Macular Degeneration - January 17, 2019
- Ferrari (NYSE:RACE) Results and Guidance Likely to Surprise - January 17, 2019